PILMAN » NCE http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 The Challenge of Holistic Value Creation With Pharma M&A http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/?utm_source=rss&utm_medium=rss&utm_campaign=the-challenge-of-holistic-value-creation-with-pharma-ma http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/#comments Mon, 19 Aug 2019 00:00:58 +0000 Tapan Ray http://www.tapanray.in/?p=9675 Continue reading →]]> http://www.tapanray.in/the-challenge-of-holistic-value-creation-with-pharma-ma/feed/ 0 Draft Pharma Policy 2017 And Branded Generics http://www.tapanray.in/draft-pharma-policy-2017-and-branded-generics/?utm_source=rss&utm_medium=rss&utm_campaign=draft-pharma-policy-2017-and-branded-generics http://www.tapanray.in/draft-pharma-policy-2017-and-branded-generics/#comments Sun, 27 Aug 2017 23:55:24 +0000 Tapan Ray http://www.tapanray.in/?p=8385 Continue reading →]]> http://www.tapanray.in/draft-pharma-policy-2017-and-branded-generics/feed/ 0 ‘Data Protection’: Needs A Clear Direction…But Is It An IPR Issue? http://www.tapanray.in/data-protection-needs-a-clear-directionbut-is-it-an-ipr-issue/?utm_source=rss&utm_medium=rss&utm_campaign=data-protection-needs-a-clear-directionbut-is-it-an-ipr-issue http://www.tapanray.in/data-protection-needs-a-clear-directionbut-is-it-an-ipr-issue/#comments Mon, 02 Mar 2015 00:00:51 +0000 Tapan Ray http://www.tapanray.in/?p=6397 Continue reading →]]> http://www.tapanray.in/data-protection-needs-a-clear-directionbut-is-it-an-ipr-issue/feed/ 0 Supreme Court Suspends New Drug Trials in India…Time to Shape Up? http://www.tapanray.in/supreme-court-suspends-new-drug-trials-in-india-time-to-shape-up/?utm_source=rss&utm_medium=rss&utm_campaign=supreme-court-suspends-new-drug-trials-in-india-time-to-shape-up http://www.tapanray.in/supreme-court-suspends-new-drug-trials-in-india-time-to-shape-up/#comments Mon, 14 Oct 2013 00:00:21 +0000 Tapan Ray http://www.tapanray.in/?p=3839 Continue reading →]]> http://www.tapanray.in/supreme-court-suspends-new-drug-trials-in-india-time-to-shape-up/feed/ 0 R&D: Is Indian Pharma Moving Up the Value Chain? http://www.tapanray.in/rd-is-indian-pharma-moving-up-the-value-chain/?utm_source=rss&utm_medium=rss&utm_campaign=rd-is-indian-pharma-moving-up-the-value-chain http://www.tapanray.in/rd-is-indian-pharma-moving-up-the-value-chain/#comments Mon, 02 Sep 2013 00:00:29 +0000 Tapan Ray http://www.tapanray.in/?p=3530 Continue reading →]]> http://www.tapanray.in/rd-is-indian-pharma-moving-up-the-value-chain/feed/ 0 Balancing IPR with Public Health Interest: Brickbats, Power Play and Bouquets http://www.tapanray.in/balancing-ipr-with-public-health-interest-brickbats-power-play-and-bouquets/?utm_source=rss&utm_medium=rss&utm_campaign=balancing-ipr-with-public-health-interest-brickbats-power-play-and-bouquets http://www.tapanray.in/balancing-ipr-with-public-health-interest-brickbats-power-play-and-bouquets/#comments Mon, 01 Jul 2013 00:00:39 +0000 Tapan Ray http://www.tapanray.in/?p=2691 Continue reading →]]> http://www.tapanray.in/balancing-ipr-with-public-health-interest-brickbats-power-play-and-bouquets/feed/ 0 A Force Multiplier: An “Armageddon”: A Contender for Supremacy in the Generic Pharma World http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/?utm_source=rss&utm_medium=rss&utm_campaign=a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/#comments Mon, 22 Apr 2013 00:00:26 +0000 Tapan Ray http://www.tapanray.in/?p=2193 Continue reading →]]> http://www.tapanray.in/a-force-multiplier-an-armageddon-a-contender-for-supremacy-in-the-generic-pharma-world/feed/ 0 Arresting continuous job losses in the global pharma industry call for innovation across the value chain http://www.tapanray.in/arresting-continuous-job-losses-in-the-global-pharma-industry-call-for-innovation-across-the-value-chain/?utm_source=rss&utm_medium=rss&utm_campaign=arresting-continuous-job-losses-in-the-global-pharma-industry-call-for-innovation-across-the-value-chain http://www.tapanray.in/arresting-continuous-job-losses-in-the-global-pharma-industry-call-for-innovation-across-the-value-chain/#comments Mon, 05 Mar 2012 00:00:09 +0000 Tapan Ray http://tapanray.in/index.php/?p=125 Continue reading →]]> http://www.tapanray.in/arresting-continuous-job-losses-in-the-global-pharma-industry-call-for-innovation-across-the-value-chain/feed/ 0 Should high prices of new drugs, causing low access to majority of patients, be attributed to high R&D cost? http://www.tapanray.in/should-high-prices-of-new-drugs-causing-low-access-to-majority-of-patients-be-attributed-to-high-rd-cost/?utm_source=rss&utm_medium=rss&utm_campaign=should-high-prices-of-new-drugs-causing-low-access-to-majority-of-patients-be-attributed-to-high-rd-cost http://www.tapanray.in/should-high-prices-of-new-drugs-causing-low-access-to-majority-of-patients-be-attributed-to-high-rd-cost/#comments Mon, 13 Feb 2012 00:00:19 +0000 Tapan Ray http://tapanray.in/index.php/?p=134 Continue reading →]]> http://www.tapanray.in/should-high-prices-of-new-drugs-causing-low-access-to-majority-of-patients-be-attributed-to-high-rd-cost/feed/ 0 Tapan Ray in ‘Focus Reports’, March 2011 http://www.tapanray.in/tapan-ray-in-focus-reports-march-2011/?utm_source=rss&utm_medium=rss&utm_campaign=tapan-ray-in-focus-reports-march-2011 http://www.tapanray.in/tapan-ray-in-focus-reports-march-2011/#comments Mon, 04 Apr 2011 00:30:11 +0000 Tapan Ray http://tapanray.in/index.php/?p=281 Continue reading →]]> http://www.tapanray.in/tapan-ray-in-focus-reports-march-2011/feed/ 0